Buprenorphine Maintenance for Opiate Dependence - 6
NCT00000357 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL
Last updated 2017-01-12
Summary
The purpose of this study is to determine the efficacy of buprenorphine as a substitution pharmacotherapy for opiate dependence.
Conditions
- Opioid-Related Disorders
- Substance-Related Disorders
Interventions
- DRUG
-
Buprenorphine
Sponsors & Collaborators
- collaborator OTHER
-
National Institute on Drug Abuse (NIDA)
lead NIH
Principal Investigators
-
Charles O'Brien, M.D., Ph.D. · PDVAMC Treatment Research Center
Study Design
- Purpose
- TREATMENT
Eligibility
- Sex
- MALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 1992-06-30
- Primary Completion
- 1993-08-31
- Completion
- 1993-10-31
Countries
- United States
Study Locations
More Related Trials
-
Buprenorphine as a Treatment for Individuals Dependent on Analgesic Opioids
NCT00218101 ·Status: COMPLETED ·Phase: PHASE2
-
Buprenorphine as a Treatment in Opiate Dependent Pain Patients
NCT00552578 ·Status: TERMINATED ·Phase: PHASE4
-
Alternate-Day Buprenorphine Administration. Phase VI - 7
NCT00000225 ·Status: COMPLETED ·Phase: PHASE2
-
A Within Subject Comparison of Opioid Withdrawal in Opioid Dependent Individuals
NCT01136356 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Buprenorphine Treatment for Opioid Dependence
NCT02187198 ·Status: COMPLETED ·Phase: PHASE3
-
Study Comparing Liquid and Tablet Buprenorphine Formulations - 5
NCT00000302 ·Status: COMPLETED ·Phase: PHASE3
-
Blockade Efficacy of Buprenorphine/Naloxone For Opioid Dependence
NCT00134888 ·Status: COMPLETED ·Phase: NA
-
Buprenorphine Treatment: A Safe Alternative for Opioid Dependent Pain Patients
NCT01841931 ·Status: TERMINATED ·Phase: PHASE4
-
Buprenorphine Physician-Pharmacist Collaboration in the Management of Patients With Opioid Use Disorder: CTN 0075
NCT03248947 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Buprenorphine Pharmacology Related to Addiction Treatment - 21
NCT00000239 ·Status: COMPLETED ·Phase: PHASE2
-
Alternate Day Buprenorphine Administration, Phase IX - 14
NCT00000232 ·Status: COMPLETED ·Phase: PHASE2
-
Alternate-Day Buprenorphine Administration. Phase VIII - 9
NCT00000227 ·Status: COMPLETED ·Phase: PHASE2
-
Alternate Day Buprenorphine Administration, Phase XI - 16
NCT00000234 ·Status: COMPLETED ·Phase: PHASE2
-
Effects of Buprenorphine/Naloxone Administered in Different Ways For Treating Opioid Dependence
NCT00134914 ·Status: COMPLETED ·Phase: NA
-
Alternate-Day Buprenorphine Administration. Phase II - 4
NCT00000222 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluation of Liquid vs. Tablet Buprenorphine - 6
NCT00000341 ·Status: COMPLETED ·Phase: PHASE2
-
Treatment Seeking Participants With Opioid Use Disorders Assessing Tolerability of Depot Injections of Buprenorphine
NCT02357901 ·Status: COMPLETED ·Phase: PHASE3
-
Alternate Day Buprenorphine Administration, Phase X - 15
NCT00000233 ·Status: COMPLETED ·Phase: PHASE2
-
Low-dose Buprenorphine Initiation for Opioid Use Disorder
NCT05450718 ·Status: RECRUITING ·Phase: PHASE4
-
Alternate-Day Buprenorphine Administration. Phase IV - 5
NCT00000223 ·Status: COMPLETED ·Phase: PHASE2
-
Alternate-Day Buprenorphine Administration. Phase I - 3
NCT00000221 ·Status: COMPLETED ·Phase: PHASE1
-
Buprenorphine and Naloxone for the Treatment of Opiate Dependence - 1
NCT00015171 ·Status: COMPLETED ·Phase: PHASE3
-
Oral Buprenorphine as a Novel Low-dose Induction Strategy for Opioid Use Disorder
NCT06086275 ·Status: COMPLETED ·Phase: PHASE1
-
Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment III) - 3
NCT00000328 ·Status: WITHDRAWN ·Phase: PHASE2
-
Buprenorphine Dosing Interval - 5
NCT00000209 ·Status: COMPLETED ·Phase: PHASE2